Correlation Between Phio Pharmaceuticals and Ensysce Biosciences

Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and Ensysce Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and Ensysce Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Phio Pharmaceuticals Corp and Ensysce Biosciences, you can compare the effects of market volatilities on Phio Pharmaceuticals and Ensysce Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of Ensysce Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and Ensysce Biosciences.

Diversification Opportunities for Phio Pharmaceuticals and Ensysce Biosciences

-0.41

Correlation Coefficient

Phio Pharmaceuticals  Ensysce Biosciences

Very good diversification

The 3 months correlation between Phio and Ensysce is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and Ensysce Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ensysce Biosciences and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with Ensysce Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ensysce Biosciences has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and Ensysce Biosciences go up and down completely randomly.

Pair Corralation between Phio Pharmaceuticals and Ensysce Biosciences

Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to under-perform the Ensysce Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Phio Pharmaceuticals Corp is 1.35 times less risky than Ensysce Biosciences. The stock trades about -0.04 of its potential returns per unit of risk. The Ensysce Biosciences is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  14,580  in Ensysce Biosciences on September 25, 2024 and sell it today you would lose (13,660) from holding Ensysce Biosciences or give up 93.69% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	99.8%
Values	Daily Returns

Phio Pharmaceuticals Corp  vs.  Ensysce Biosciences

Phio Pharmaceuticals Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Phio Pharmaceuticals Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Ensysce Biosciences

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Ensysce Biosciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Ensysce Biosciences exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Phio Pharmaceuticals and Ensysce Biosciences

The main advantage of trading using opposite Phio Pharmaceuticals and Ensysce Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, Ensysce Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ensysce Biosciences will offset losses from the drop in Ensysce Biosciences' long position.

The idea behind Phio Pharmaceuticals Corp and Ensysce Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.